{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:20:19Z","timestamp":1753888819437,"version":"3.41.2"},"reference-count":22,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,6]]},"DOI":"10.20945\/2359-4292-2023-0315","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T17:58:03Z","timestamp":1731002283000},"source":"Crossref","is-referenced-by-count":0,"title":["PTH immunoassay interference: differential diagnosis with normocalcemic primary hyperparathyroidism?"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-7185","authenticated-orcid":false,"given":"Monique Nakayama","family":"Ohe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3530-9997","authenticated-orcid":false,"given":"Roberto Massao","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-6058","authenticated-orcid":false,"given":"Claudia M. Aparecida de Francischi","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-4215","authenticated-orcid":false,"suffix":"Junior","given":"Jose","family":"Viana Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-6622","authenticated-orcid":false,"given":"Rosa Paula","family":"Biscolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7121-4458","authenticated-orcid":false,"given":"Jos\u00e9 Gilberto Henriques","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9606-2841","authenticated-orcid":false,"given":"Maria Izabel","family":"Chiamolera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"4","key":"key20241107175757_B1","doi-asserted-by":"crossref","first-page":"bvad013","DOI":"10.1210\/jendso\/bvad013","article-title":"The Eucalcemic Patient with Elevated Parathyroid Hormone Levels","volume":"7","author":"Shaker","year":"2023","unstructured":"1 Shaker JL, Wermers RA. The Eucalcemic Patient with Elevated Parathyroid Hormone Levels. J Endocr Soc. 2023 Jan 26;7(4):bvad013. doi: 10.1210\/jendso\/bvad013.","journal-title":"J Endocr Soc"},{"issue":"1-2","key":"key20241107175757_B2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2007.08.019","article-title":"False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice","volume":"387","author":"Cavalier","year":"2008","unstructured":"2 Cavalier E, Carlisi A, Chapelle JP, Delanaye P. False positive PTH results: an easy strategy to test and detect analytical interferences in routine practice. Clin Chim Acta. 2008 Jan;387(1-2):150-2. doi: 10.1016\/j.cca.2007.08.019.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"key20241107175757_B3","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00198-021-05950-2","article-title":"Asymptomatic elevated parathyroid hormone level due to immunoassay interference","volume":"32","author":"Zanchetta","year":"2021","unstructured":"3 Zanchetta MB, Giacoia E, Jerkovich F, Fradinger E. Asymptomatic elevated parathyroid hormone level due to immunoassay interference. Osteoporos Int. 2021 Oct;32(10):2111-4. doi: 10.1007\/s00198-021-05950-2.","journal-title":"Osteoporos Int"},{"issue":"2","key":"key20241107175757_B4","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4158\/EP10235.CR","article-title":"Falsely elevated plasma parathyroid hormone level mimicking tertiary hyperparathyroidism","volume":"17","author":"Levin","year":"2011","unstructured":"4 Levin O, Morris LF, Wah DT, Butch AW, Yeh MW. Falsely elevated plasma parathyroid hormone level mimicking tertiary hyperparathyroidism. Endocr Pract. 2011 Mar-Apr;17(2):e8-11. doi: 10.4158\/EP10235.CR.","journal-title":"Endocr Pract"},{"issue":"7","key":"key20241107175757_B5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/a-1856-4900","article-title":"The Diagnosis of Normocalcaemic Hyperparathyroidism is Strikingly Dissimilar Using Different Commercial Laboratory Assays","volume":"54","author":"Kalaria","year":"2022","unstructured":"5 Kalaria T, Fenn J, Sanders A, Yates A, Duff C, Ashby H, et al. The Diagnosis of Normocalcaemic Hyperparathyroidism is Strikingly Dissimilar Using Different Commercial Laboratory Assays. Horm Metab Res. 2022 Jul;54(7):429-34. doi: 10.1055\/a-1856-4900.","journal-title":"Horm Metab Res"},{"issue":"4","key":"key20241107175757_B6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1590\/S0004-27302006000400007","article-title":"Evolution of PTH assays","volume":"50","author":"Vieira","year":"2006","unstructured":"6 Vieira JG, Kunii I, Nishida S. Evolution of PTH assays. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):621-7. doi: 10.1590\/s0004-27302006000400007.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"5","key":"key20241107175757_B7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","unstructured":"7 Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013 Oct;27(5):647-61. doi: 10.1016\/j.beem.2013.05.011.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"key20241107175757_B8","first-page":"105","article-title":"Interferences in immunoassay","volume":"25","author":"Tate","year":"2004","unstructured":"8 Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev. 2004 May;25(2):105-20.","journal-title":"Clin Biochem Rev"},{"issue":"9","key":"key20241107175757_B9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1590\/S0100-879X2005000900013","article-title":"Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985 to 2002","volume":"38","author":"Ohe","year":"2005","unstructured":"9 Ohe MN, Santos RO, Barros ER, Lage A, Kunii IS, Abrah\u00e3o M, et al. Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in Sao Paulo from 1985 to 2002. Braz J Med Biol Res. 2005 Sep;38(9):1383-7. doi: 10.1590\/s0100-879x2005000900013.","journal-title":"Braz J Med Biol Res"},{"issue":"7","key":"key20241107175757_B10","doi-asserted-by":"crossref","first-page":"dgaa174","DOI":"10.1210\/clinem\/dgaa174","article-title":"Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism","volume":"105","author":"Palermo","year":"2020","unstructured":"10 Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, et al. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa174. doi: 10.1210\/clinem\/dgaa174.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10116","key":"key20241107175757_B11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","unstructured":"11 Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018 Jan 13;391(10116):168-78. doi: 10.1016\/S0140-6736(17)31430-7.","journal-title":"Lancet"},{"key":"key20241107175757_B12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12902-015-0077-3","article-title":"Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study","volume":"15","author":"Nakamura","year":"2015","unstructured":"12 Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, et al. Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study. BMC Endocr Disord. 2015 Dec 15;15:81. doi: 10.1186\/s12902-015-0077-3.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"key20241107175757_B13","first-page":"237","article-title":"Falsely elevated serum estradiol due to heterophile antibody interference: a case report","volume":"65","author":"Atkins","year":"2021","unstructured":"13 Atkins P, Mattman A, Thompson D. Falsely elevated serum estradiol due to heterophile antibody interference: a case report. Arch Endocrinol Metab. 2021 Nov 1;65(2):237-21. doi: 10.20945\/2359-3997000000324.","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"key20241107175757_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cll.2004.01.003","article-title":"Interferences in hormone immunoassays","volume":"24","author":"Klee","year":"2004","unstructured":"14 Klee GG. Interferences in hormone immunoassays. Clin Lab Med. 2004 Mar;24(1):1-18. doi: 10.1016\/j.cll.2004.01.003.","journal-title":"Clin Lab Med"},{"issue":"Pt 5","key":"key20241107175757_B15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1258\/acb.2011.011073","article-title":"Analytical error and interference in immunoassay: minimizing risk","volume":"48","author":"Sturgeon","year":"2011","unstructured":"15 Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem. 2011 Sep;48(Pt 5):418-32. doi: 10.1258\/acb.2011.011073.","journal-title":"Ann Clin Biochem"},{"issue":"12","key":"key20241107175757_B16","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1210\/jc.2019-01321","article-title":"PTH Immunoassay Interference Due to Human Anti-Mouse Antibodies in a Subject with Obesity with Normal Parathyroid Function","volume":"104","author":"Laudes","year":"2019","unstructured":"16 Laudes M, Frohnert J, Ivanova K, Wandinger KP. PTH Immunoassay Interference Due to Human Anti-Mouse Antibodies in a Subject with Obesity with Normal Parathyroid Function. J Clin Endocrinol Metab. 2019 Dec 1;104(12):5840-2. doi: 10.1210\/jc.2019-01321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key20241107175757_B17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ccr3.1664","article-title":"Normocalcemia but still elevated parathyroid hormone levels after parathyroidectomy","volume":"6","author":"van der Doelen","year":"2018","unstructured":"17 van der Doelen RHA, Nijhuis P, van der Velde R, Janssen MJW. Normocalcemia but still elevated parathyroid hormone levels after parathyroidectomy. Clin Case Rep. 2018 Jun 25;6(8):1577-81. doi: 10.1002\/ccr3.1664.","journal-title":"Clin Case Rep"},{"issue":"3","key":"key20241107175757_B18","first-page":"164","article-title":"Inappropriate treatment of prostate cancer caused by heterophilic antibody interference","volume":"6","author":"Henry","year":"2009","unstructured":"18 Henry N, Sebe P, Cussenot O. Inappropriate treatment of prostate cancer caused by heterophilic antibody interference. Nat Clin Pract Urol. 2009 Mar;6(3):164-7. doi: 10.1038\/ncpuro1317.","journal-title":"Nat Clin Pract Urol"},{"issue":"8","key":"key20241107175757_B19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/clinchem\/32.8.1491","article-title":"Incidence and specificity of interference in two-site immunoassays","volume":"32","author":"Boscato","year":"1986","unstructured":"19 Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem. 1986 Aug;32(8):1491-5.","journal-title":"Clin Chem"},{"issue":"4","key":"key20241107175757_B20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ajcp\/108.4.417","article-title":"Heterophilic antibodies remain a problem for the immunoassay laboratory","volume":"108","author":"Ward","year":"1997","unstructured":"20 Ward G, McKinnon L, Badrick T, Hickman PE. Heterophilic antibodies remain a problem for the immunoassay laboratory. Am J Clin Pathol. 1997 Oct;108(4):417-21. doi: 10.1093\/ajcp\/108.4.417.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"key20241107175757_B21","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2003-030122","article-title":"Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays","volume":"88","author":"Preissner","year":"2003","unstructured":"21 Preissner CM, O\u2019Kane DJ, Singh RJ, Morris JC, Grebe SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab. 2003 Jul;88(7):3069-74. doi: 10.1210\/jc.2003-030122.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20241107175757_B22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1515\/cclm-2016-0606","article-title":"False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences","volume":"55","author":"Piketty","year":"2017","unstructured":"22 Piketty ML, Polak M, Flechtner I, Gonzales-Brice\u00f1o L, Souberbielle JC. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med. 2017 May 1;55(6):780-8. doi: 10.1515\/cclm-2016-0606.","journal-title":"Clin Chem Lab Med"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T17:58:09Z","timestamp":1731002289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/pth-immunoassay-interference-differential-diagnosis-with-normocalcemic-primary-hyperparathyroidism\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":22,"alternative-id":["10.20945\/2359-4292-2023-0315"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0315","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230315"}}